Rankings
▼
Calendar
EYPT Q2 2017 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$701,000
+130.6% YoY
Gross Profit
$701,000
100.0% margin
Operating Income
-$6M
-875.3% margin
Net Income
-$6M
-872.5% margin
EPS (Diluted)
$-1.58
QoQ Revenue Growth
+18.8%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$5M
Stock-Based Comp.
$682,000
Balance Sheet
Total Assets
$19M
Total Liabilities
$5M
Stockholders' Equity
$13M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$701,000
$304,000
+130.6%
Gross Profit
$701,000
-$4M
+118.4%
Operating Income
-$6M
-$6M
+5.0%
Net Income
-$6M
-$6M
+4.2%
← FY 2017
All Quarters
Q3 2017 →